IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development
SAN RAFAEL, Calif.–(BUSINESS WIRE)–IMIDomics, a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases... Read more.
BostonGene to Present at the 2023 San Antonio Breast Cancer Symposium
Presentation Reveals BostonGene-developed Transcriptomic Classification Tool for the Precise Identification of Breast Cancer Subtypes Study with Leading Cancer Center... Read more.
Cigniti Named as a Major Player in IDC MarketScape: Worldwide Software Engineering Services 2023 Vendor Assessment
DALLAS–(BUSINESS WIRE)–#AI–Cigniti Technologies, the world’s leading AI & IP-led Digital Assurance and Digital Engineering services company... Read more.
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 – POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc.... Read more.
Nordson Corporation Declares First Quarter Dividend for Fiscal Year 2024
WESTLAKE, Ohio–(BUSINESS WIRE)–Nordson Corporation (Nasdaq: NDSN) today announced that its board of directors declared a fiscal year 2024 first quarter... Read more.
New Cathay World Elite® Mastercard® – powered by Neo now available
First World Elite® Mastercard® in Canada with a secured credit option, tailored to new Canadian customers CALGARY, Alberta & WINNIPEG, Manitoba–(BUSINESS... Read more.
TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
— Results of Phase 3 HER2CLIMB-02 trial featured in an oral presentation and official press program at the 2023 San Antonio Breast Cancer Symposium —... Read more.
CatalYm Presents Positive Phase 2a Outcome for Visugromab in Advanced NSCLC and Urothelial Cancer at the ESMO Immuno-Oncology Congress 2023
– Visugromab demonstrated potent and durable clinical efficacy as well as excellent tolerability in combination with nivolumab in advanced-stage/last-line... Read more.
Stratasys Partners with National Occupational Competency Testing Institute to Introduce First-Ever FDM Process Certification
Additive Manufacturing Students Have the Best Training Possible for Their Entry Into the Job Market; Schools Gain Access to New Revenue EDEN PRAIRIE, Minn. &... Read more.
Biospectal OptiBP Receives First-Ever CE Mark for a Smartphone Blood Pressure Monitoring App
The Biospectal OptiBP app is the first and only software-only blood pressure monitoring solution on smartphones to receive the CE Mark, democratizing worldwide access... Read more.